Contrary to concerns that telemedicine could be overused, some programs are seeing lower involvement than expected, according to Anne Schmidt, MD, associate medical director at Blue Cross and Blue Shield of Alabama.
Contrary to concerns that telemedicine could be overused, some programs are seeing lower involvement than expected, according to Anne Schmidt, MD, associate medical director at Blue Cross and Blue Shield of Alabama.
Transcript (slightly modified)
Overutilization is one of the concerns with telemedicine. What are some of the challenges with controlling utilization of telemedicine?
For utilization of telemedicine, I think what we’re seeing is there’s actually less utilization than we’d expected. We have a teledoc program which we consider telehealth, versus a true telemedicine program, which we would define as a synchronous one-on-one interaction with a physician, a scheduled interaction, so say a consultation with a dermatologist or an infectious disease consultant. So we try to keep that distinct from telehealth, which I think is what we’re talking about with diabetes.
The utilization hasn’t been as high as we’d even expected with the specialty telemedicine programs, and we’re really trying to promote that. As far as overutilization, I think we might be looking at the wrong side. I think we need to engage more folks in their own healthcare and get them involved, and so I really don’t think we’ve seen overutilization of any programs that have so far been implemented.
As far as with reimbursement, again, we’ll have to look at data to see what the outcomes are for the general wellness programs, but I think the more involved that we can get patients in their own healthcare, and if telehealth is the way to do that, then I think everybody would benefit.
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More